title: In response to Dr. Formenti et al. (Int J Radiat Oncol Biol Phys 2005, 63:1275-1276).
authors.forename: Johnny
authors.initials: J
authors.lastname: Kao
authors.forename: Suzanne
authors.initials: S
authors.lastname: Conzen
authors.forename: Gini
authors.initials: G
authors.lastname: Fleming
authors.forename: Wendy
authors.initials: W
authors.lastname: Recant
authors.forename: Ruth
authors.initials: R
authors.lastname: Heimann
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D003131:Combined Modality Therapy; D003627:Data Interpretation, Statistical; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel